BackGoodRx Holdings Overview
GoodRx Holdings Inc - Ordinary Shares - Class A

GoodRx Holdings Target Price

Analysts' average 12-month price target for GoodRx Holdings is $4.1.

Get informed when a big investor buys or sells

+ Follow

Share Price

$3.48

Average Target Price

$4.0516.5% upside

5 analysts in the last 4 months

High: $5 | Low: $3.5

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-20Barclays$415.1% upsideOpen
2026-08-13UBS$3.757.9% upsideOpen
2026-08-07Goldman Sachs$415.1% upsideOpen
2026-08-06Leerink Partners$543.9% upsideOpen
2026-05-08Goldman SachsEric Sheridan$3.50.7% upsideOpen
2026-02-26Leerink PartnersMichael Cherny$313.7% downsideOpen
2026-01-22JefferiesGlen Santangelo$2.7520.9% downsideOpen
2025-12-18Morgan Stanley$415.1% upsideOpen
2025-12-08Barclays$313.7% downsideOpen
2025-08-11Deutsche BankGeorge Hill$672.7% upsideOpen
2024-06-10Morgan StanleyCraig Hettenbach$9.5173.4% upsideOpen
2024-05-23RBC CapitalMark Mahaney$10187.8% upsideOpen
2024-05-16BarclaysStephanie Davis$9159% upsideOpen
2024-05-16Raymond JamesAaron Kessler$10187.8% upsideOpen
2024-04-10BOCOM International Holdings CompanyScott Schoenhaus$9159% upsideOpen
2024-04-10KeyBancScott Schoenhaus$9159% upsideOpen
2024-03-25Wells FargoStan Berenshteyn$10187.8% upsideOpen
2023-11-13Goldman SachsEric Sheridan$313.7% downsideOpen
2022-12-01Citigroup$7101.4% upsideOpen
2022-08-09BarclaysSteve Valiquette$13274.1% upsideOpen
2022-06-07Robert W. BairdVikram Kesavabhotla$7101.4% upsideOpen
2022-05-12Wells FargoStan Berenshteyn$9159% upsideOpen
2022-03-01J.P. MorganDoug Anmuth$20475.5% upsideOpen
2022-03-01Cowen & Co.Charles Rhyee$22533.1% upsideOpen
2022-03-01Goldman SachsEric Sheridan$30763.3% upsideOpen
2022-03-01Deutsche BankGeorge Hill$20475.5% upsideOpen
2022-03-01Bank of America SecuritiesJustin Post$28705.8% upsideOpen
2021-12-21StephensScott Schoenhaus$451195% upsideOpen
2021-05-14CitigroupNicholas Jones CFA$531425.2% upsideOpen

GoodRx Holdings (GDRX) FAQ

The latest target price for GDRX is $4.1. Investors often review this figure alongside GoodRx Holdings's historical trend and sector peers before judging valuation or financial health.

GoodRx Holdings trades near $3.48 while the consensus target sits at $4.1 (16.5% upside). Targets are estimates based on earnings forecasts and valuation models; they change when analysts update ratings or revise models. Compare the average with the high and low targets for a fuller picture.

After noting GDRX's target price ($4.1), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack GoodRx Holdings's target price against similar Technology names. You can also browse sector and industry screens on Stockcircle for a broader set of Technology companies and their key multiples and fundamentals.